Ultragenyx Pharmaceutical, Inc. (RARE)
23.67
-0.04
(-0.17%)
USD |
NASDAQ |
May 22, 09:49
Ultragenyx Pharmaceutical Shareholders Equity (Quarterly) : -236.00M for March 31, 2026
Shareholders Equity (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Shareholders' Equity Definition
Shareholder's Equity is a main portion of the balance sheet of a company that measures the net value of a company. The reason for this is because the from an accounting perspective, the balance sheet equation is Shareholder's Equity = Assets - Liabilities. A few examples of shareholder's equity of a company include retained earnings, paid in capital, and preferred stock.
Shareholders Equity (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Shareholders Equity (Quarterly) Benchmarks
| Catalyst Pharmaceuticals, Inc. | 1.013B |
| BioMarin Pharmaceutical, Inc. | 6.212B |
| Regeneron Pharmaceuticals, Inc. | 31.42B |
| Xencor, Inc. | 515.63M |
| REGENXBIO, Inc. | 21.08M |
Shareholders Equity (Quarterly) Related Metrics
| Total Assets (Quarterly) | 1.296B |
| Total Liabilities (Quarterly) | 1.525B |
| Debt to Equity Ratio | -5.085 |
| Current Ratio | 2.022 |
| Net Debt Paydown Yield | -2.82% |